Vimarsana
Biggest News Aggregation in the World

Page 18 - Recent Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recent Updates Today - Breaking & Trending Today

Initiating Treatment for Lower-Risk MDS With Symptomatic Anemia - Vimarsana News

Initiating Treatment for Lower-Risk MDS With Symptomatic Anemia

The panel shares at what point they decide to start treatment for patients with lower-risk MDS and symptomatic anemia.

First-Line Treatment Options for Lower-Risk MDS With Symptomatic Anemia - Vimarsana News

First-Line Treatment Options for Lower-Risk MDS With Symptomatic Anemia

Yazan Madanat, MD, details the available options for first-line treatment of patients with lower-risk MDS and symptomatic anemia.

Unsubscribing From Snapchat: What To Consider Before You Make The Decision - Vimarsana News

Unsubscribing From Snapchat: What To Consider Before You Make The Decision

If you are an avid user of the popular social media platform Snapchat, you may have been tempted to unsubscribe from the service at one point or another. Unsubscribing from an online service can be a daunting decision, and it’s important to consider the potential consequences of your choice before making the final call. In […]

Perioperative Treatment in Early-Stage NSCLC: AEGEAN Study - Vimarsana News

Perioperative Treatment in Early-Stage NSCLC: AEGEAN Study

David Harpole, MD, discusses study design, results and clinical implications of the AEGEAN study of perioperative immunotherapy (neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in the treatment of early-stage NSCLC

COMING SOON: Recent Updates in Hepatocellular Carcinoma (HCC) and Evolving Treatment Paradigms - Vimarsana News

COMING SOON: Recent Updates in Hepatocellular Carcinoma (HCC) and Evolving Treatment Paradigms

Rachna Shroff, MD, provides a look at an upcoming program reviewing recent data updates in the treatment of hepatocellular carcinoma.